TTK Income Tax Expense vs Research Development Analysis

TTKHLTCARE

1,454 4.35 0.30%

TTK Healthcare financial indicator trend analysis is much more than just breaking down TTK Healthcare prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether TTK Healthcare is a good investment. Please check the relationship between TTK Healthcare Income Tax Expense and its Research Development accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TTK Healthcare Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Income Tax Expense vs Research Development

Income Tax Expense vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of TTK Healthcare Income Tax Expense account and Research Development. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between TTK Healthcare's Income Tax Expense and Research Development is -0.09. Overlapping area represents the amount of variation of Income Tax Expense that can explain the historical movement of Research Development in the same time period over historical financial statements of TTK Healthcare Limited, assuming nothing else is changed. The correlation between historical values of TTK Healthcare's Income Tax Expense and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Tax Expense of TTK Healthcare Limited are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Income Tax Expense i.e., TTK Healthcare's Income Tax Expense and Research Development go up and down completely randomly.

Correlation Coefficient

-0.09

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Income Tax Expense

Research Development

Most indicators from TTK Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into TTK Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TTK Healthcare Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

As of November 28, 2024, Selling General Administrative is expected to decline to about 92.5 M. In addition to that, Tax Provision is expected to decline to about 113 M

	2021	2022	2023	2024 (projected)
Gross Profit	3.1B	3.8B	2.7B	2.5B
Total Revenue	6.0B	7.3B	7.5B	4.8B

Gross Profit Total Revenue

TTK Healthcare fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Net Receivables	Current Deferred Revenue	Short Term Debt
Total Assets		-0.11	0.39	0.59	1.0	0.1	0.52	0.98	0.6	-0.55	0.28	0.77	0.99	0.75	0.99	-0.67	0.91	0.87	0.27	0.57	1.0	-0.74	0.62	-0.12	0.16	0.1
Short Long Term Debt Total	-0.11		-0.02	0.1	-0.14	0.63	0.1	-0.16	-0.06	0.16	0.53	-0.1	-0.18	-0.17	-0.19	0.23	-0.09	-0.02	-0.38	0.15	-0.16	0.4	0.01	0.12	-0.42	0.8
Other Current Liab	0.39	-0.02		0.71	0.33	0.36	-0.12	0.31	0.29	0.12	0.34	0.17	0.35	0.25	0.32	-0.17	0.52	0.3	0.43	0.75	0.37	-0.44	0.32	0.16	0.26	-0.04
Total Current Liabilities	0.59	0.1	0.71		0.52	0.55	0.51	0.45	0.86	-0.48	0.69	0.16	0.5	0.21	0.52	-0.59	0.78	0.73	0.2	0.99	0.55	-0.4	0.85	0.53	0.37	0.27
Total Stockholder Equity	1.0	-0.14	0.33	0.52		0.04	0.5	0.99	0.55	-0.54	0.23	0.79	0.99	0.77	0.99	-0.65	0.88	0.84	0.26	0.5	1.0	-0.74	0.58	-0.18	0.14	0.08
Property Plant And Equipment Net	0.1	0.63	0.36	0.55	0.04		0.29	-0.02	0.34	-0.12	0.93	-0.05	-0.04	-0.07	-0.02	-0.11	0.32	0.37	0.19	0.58	0.02	0.11	0.43	0.39	-0.25	0.69
Net Debt	0.52	0.1	-0.12	0.51	0.5	0.29		0.44	0.82	-0.97	0.53	0.3	0.44	0.27	0.51	-0.63	0.61	0.76	-0.12	0.47	0.48	-0.34	0.8	0.33	0.15	0.36
Retained Earnings	0.98	-0.16	0.31	0.45	0.99	-0.02	0.44		0.48	-0.49	0.15	0.8	0.99	0.78	0.99	-0.6	0.83	0.79	0.27	0.43	0.99	-0.75	0.5	-0.25	0.13	0.04
Accounts Payable	0.6	-0.06	0.29	0.86	0.55	0.34	0.82	0.48		-0.82	0.57	0.16	0.52	0.18	0.57	-0.7	0.76	0.8	0.04	0.82	0.57	-0.43	0.94	0.57	0.46	0.2
Cash	-0.55	0.16	0.12	-0.48	-0.54	-0.12	-0.97	-0.49	-0.82		-0.39	-0.34	-0.49	-0.32	-0.57	0.69	-0.64	-0.77	0.01	-0.42	-0.53	0.45	-0.79	-0.28	-0.25	-0.16
Non Current Assets Total	0.28	0.53	0.34	0.69	0.23	0.93	0.53	0.15	0.57	-0.39		0.1	0.14	0.1	0.17	-0.31	0.51	0.56	0.12	0.7	0.2	-0.03	0.7	0.42	-0.19	0.64
Non Currrent Assets Other	0.77	-0.1	0.17	0.16	0.79	-0.05	0.3	0.8	0.16	-0.34	0.1		0.76	0.97	0.75	-0.49	0.66	0.59	0.37	0.14	0.77	-0.54	0.32	-0.65	-0.18	0.06
Cash And Short Term Investments	0.99	-0.18	0.35	0.5	0.99	-0.04	0.44	0.99	0.52	-0.49	0.14	0.76		0.75	1.0	-0.61	0.84	0.79	0.25	0.47	1.0	-0.77	0.52	-0.19	0.2	0.01
Common Stock Shares Outstanding	0.75	-0.17	0.25	0.21	0.77	-0.07	0.27	0.78	0.18	-0.32	0.1	0.97	0.75		0.74	-0.46	0.64	0.56	0.38	0.18	0.75	-0.57	0.36	-0.64	-0.15	-0.03
Short Term Investments	0.99	-0.19	0.32	0.52	0.99	-0.02	0.51	0.99	0.57	-0.57	0.17	0.75	1.0	0.74		-0.65	0.86	0.83	0.24	0.49	1.0	-0.78	0.57	-0.15	0.21	0.02
Non Current Liabilities Total	-0.67	0.23	-0.17	-0.59	-0.65	-0.11	-0.63	-0.6	-0.7	0.69	-0.31	-0.49	-0.61	-0.46	-0.65		-0.71	-0.84	-0.16	-0.49	-0.66	0.32	-0.74	-0.13	-0.15	-0.3
Inventory	0.91	-0.09	0.52	0.78	0.88	0.32	0.61	0.83	0.76	-0.64	0.51	0.66	0.84	0.64	0.86	-0.71		0.92	0.37	0.77	0.88	-0.69	0.79	0.1	0.21	0.15
Other Current Assets	0.87	-0.02	0.3	0.73	0.84	0.37	0.76	0.79	0.8	-0.77	0.56	0.59	0.79	0.56	0.83	-0.84	0.92		0.28	0.68	0.83	-0.55	0.83	0.15	0.13	0.36
Other Stockholder Equity	0.27	-0.38	0.43	0.2	0.26	0.19	-0.12	0.27	0.04	0.01	0.12	0.37	0.25	0.38	0.24	-0.16	0.37	0.28		0.21	0.27	-0.39	0.06	-0.32	0.28	-0.17
Total Liab	0.57	0.15	0.75	0.99	0.5	0.58	0.47	0.43	0.82	-0.42	0.7	0.14	0.47	0.18	0.49	-0.49	0.77	0.68	0.21		0.53	-0.41	0.8	0.53	0.37	0.26
Total Current Assets	1.0	-0.16	0.37	0.55	1.0	0.02	0.48	0.99	0.57	-0.53	0.2	0.77	1.0	0.75	1.0	-0.66	0.88	0.83	0.27	0.53		-0.76	0.58	-0.15	0.19	0.05
Intangible Assets	-0.74	0.4	-0.44	-0.4	-0.74	0.11	-0.34	-0.75	-0.43	0.45	-0.03	-0.54	-0.77	-0.57	-0.78	0.32	-0.69	-0.55	-0.39	-0.41	-0.76		-0.36	0.11	-0.37	0.31
Common Stock	0.62	0.01	0.32	0.85	0.58	0.43	0.8	0.5	0.94	-0.79	0.7	0.32	0.52	0.36	0.57	-0.74	0.79	0.83	0.06	0.8	0.58	-0.36		0.43	0.2	0.26
Net Receivables	-0.12	0.12	0.16	0.53	-0.18	0.39	0.33	-0.25	0.57	-0.28	0.42	-0.65	-0.19	-0.64	-0.15	-0.13	0.1	0.15	-0.32	0.53	-0.15	0.11	0.43		0.31	0.15
Current Deferred Revenue	0.16	-0.42	0.26	0.37	0.14	-0.25	0.15	0.13	0.46	-0.25	-0.19	-0.18	0.2	-0.15	0.21	-0.15	0.21	0.13	0.28	0.37	0.19	-0.37	0.2	0.31		-0.38
Short Term Debt	0.1	0.8	-0.04	0.27	0.08	0.69	0.36	0.04	0.2	-0.16	0.64	0.06	0.01	-0.03	0.02	-0.3	0.15	0.36	-0.17	0.26	0.05	0.31	0.26	0.15	-0.38

Click cells to compare fundamentals

TTK Healthcare Account Relationship Matchups

TTK Healthcare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.3B	4.9B	5.6B	11.7B	12.0B	12.6B
Short Long Term Debt Total	298.4M	191.4M	222.1M	273.3M	228.1M	261.3M
Other Current Liab	556.9M	710.1M	931.1M	709.0M	880.6M	556.6M
Total Current Liabilities	1.7B	1.9B	2.2B	2.1B	2.0B	1.3B
Total Stockholder Equity	2.5B	2.9B	3.3B	9.5B	10.0B	10.5B
Property Plant And Equipment Net	973.5M	861.2M	804.8M	739.4M	755.9M	697.3M
Net Debt	223.1M	95.9M	73.5M	180.1M	118.5M	124.4M
Retained Earnings	1.3B	1.7B	2.0B	8.3B	8.7B	9.2B
Accounts Payable	865.1M	976.1M	1.0B	1.1B	857.4M	589.4M
Cash	75.3M	95.5M	148.6M	93.2M	109.6M	104.1M
Non Current Assets Total	1.3B	1.2B	1.1B	1.0B	1.2B	910.6M
Non Currrent Assets Other	230.0M	135.1M	70.3M	128.5M	8.4B	8.8B
Cash And Short Term Investments	1.3B	2.3B	2.7B	8.7B	8.5B	8.9B
Short Term Investments	1.2B	2.2B	2.6B	8.6B	8.3B	8.8B
Liabilities And Stockholders Equity	4.3B	4.9B	5.6B	11.7B	12.0B	12.6B
Non Current Liabilities Total	107.1M	108.6M	83.8M	59.5M	38.6M	36.7M
Inventory	716.4M	703.0M	789.2M	845.1M	969.9M	1.0B
Other Current Assets	946.0M	774.2M	966.0M	1.3B	1.4B	1.4B
Total Liab	1.8B	2.0B	2.3B	2.2B	2.0B	1.5B
Total Current Assets	3.0B	3.7B	4.5B	10.7B	10.8B	11.3B
Accumulated Other Comprehensive Income	(595.6M)	1.0B	1.0B	1.0B	1.0B	1.1B
Intangible Assets	2.4M	1.5M	863K	366K	58K	55.1K
Net Receivables	824.3M	667.4M	858.5M	921.0M	(4.5M)	(4.3M)
Current Deferred Revenue	(285.8M)	684.7M	908.1M	565.7M	6.1M	5.8M
Short Term Debt	285.8M	179.9M	208.7M	261.1M	220.1M	280.1M
Other Liab	69.7M	94.5M	97.0M	70.4M	63.4M	70.3M
Net Tangible Assets	2.5B	2.5B	2.9B	3.3B	3.8B	2.6B
Other Assets	273.3M	204.4M	144.4M	46.9M	53.9M	51.2M
Long Term Debt Total	12.6M	11.6M	13.4M	12.1M	14.0M	10.8M
Short Long Term Debt	281.3M	176.0M	203.8M	255.3M	214.7M	199.5M
Property Plant Equipment	971.8M	856.4M	803.7M	739.4M	665.5M	751.6M
Capital Lease Obligations	17.1M	15.5M	18.3M	18.0M	13.4M	14.9M
Net Invested Capital	2.8B	3.1B	3.5B	9.8B	10.2B	5.5B
Net Working Capital	1.3B	1.9B	2.3B	8.6B	8.8B	9.3B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Other Information on Investing in TTK Stock

Balance Sheet is a snapshot of the financial position of TTK Healthcare at a specified time, usually calculated after every quarter, six months, or one year. TTK Healthcare Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of TTK Healthcare and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which TTK currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

TTK Income Tax Expense vs Research Development Analysis

Income Tax Expense vs Research Development

Income Tax Expense vs Research Development Correlation Analysis

Correlation Coefficient

Income Tax Expense

Research Development

TTK Healthcare fundamental ratios Correlations

TTK Healthcare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

TTK Healthcare fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in TTK Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Stockholder Equity
Short Term Investments	+ 1.0	Cash And Short Term Investments
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Current Assets	+ 1.0	Short Term Investments

Cash	- 0.97	Net Debt
Other Current Assets	- 0.84	Non Current Liabilities Total
Cash	- 0.82	Accounts Payable
Common Stock	- 0.79	Cash
Intangible Assets	- 0.78	Short Term Investments
Intangible Assets	- 0.77	Cash And Short Term Investments